Igor Bilinsky

AmpliPhi Biosciences

Senior VP and Chief Operating Officer

Annual data

2017

In 2017, Igor Bilinsky earned a total compensation of $708.5K as Senior VP and Chief Operating Officer at AmpliPhi Biosciences.

Ranking9,898 out of 13,682
Percentile27.7%

Igor Bilinsky's 2017 compensation ranked 9,898th out of 13,682 executive pay records tracked by us this year.

Bilinsky earned more than 27.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,087 out of 1,547
Percentile29.7%

In the industry group of Drugs, Bilinsky's pay ranked 1,087th out of 1,547 executive pay records tracked by us in 2017.

Bilinsky earned more than 29.7% of executives in this group.

Non-Equity Incentive Plan$183,805
Option Awards$201,173
Salary$323,525
Total$708,503

Bilinsky received $323.5K in salary, which accounts for 45.66% of total compensation.

Bilinsky also received $183.8K in non-equity incentive plan and $201.2K in option awards.

Ignyta

Senior Vice President, Research Operations and General Manager, Immuno-Oncology

Annual data

2015

In 2015, Igor Bilinsky earned a total compensation of $2.2M as Senior Vice President, Research Operations and General Manager, Immuno-Oncology at Ignyta.

Ranking4,276 out of 13,575
Percentile68.5%

Igor Bilinsky's 2015 compensation ranked 4,276th out of 13,575 executive pay records tracked by us this year.

Bilinsky earned more than 68.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking440 out of 1,485
Percentile70.4%

In the industry group of Drugs, Bilinsky's pay ranked 440th out of 1,485 executive pay records tracked by us in 2015.

Bilinsky earned more than 70.4% of executives in this group.

Non-Equity Incentive Plan$40,803
Option Awards$2,057,000
Salary$96,635
Other$45,157
Total$2,239,595

Bilinsky received $2.1M in option awards, which accounts for 91.85% of total compensation.

Bilinsky also received $40.8K in non-equity incentive plan, $96.6K in salary and $45.2K in other compensation.